. JohnsonK, GreenD, RifeJ, LimonL. Sulfonamide cross-reactivity: fact or fiction?Ann Pharmacother2005; 39: 290–301. DOI 10.1345/aph.1E350
2.
. SupuranC, InnocentiA, MastrolorenzoA, ScozzafavaA. Antiviral sulfonamide derivatives. Mini Rev Med Chem2004; 4: 189–200.
3.
. StromBL, SchinnarR, ApterAJ, MargolisDJ, LautenbachE, HennessyS, Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics. N Engl J Med2003; 349: 1628–35.
4.
. LeoungGS, StanfordJF, GiordanoMF, SteinA, TorresRA, GiffenCA, Trimethoprim-sulfamethoxazole (TMP-SMX) dose escalation versus direct rechallenge for Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus–infected patients with previous adverse reaction to TMP-SMX. J Infect Dis2001; 184: 992–7.
5.
. CribbAE, SpielbergSP, GriffinGP. N4-hydroxylation of sulfamethoxazole by cytochrome p450 of the cytochrome p405C subfamily and reduction of sulfamethoxazole in human and rat hepatic microsomes. Drug Metab Dispos1995; 23: 406–14.
